创业慧康11月20日获融资买入3760.44万元,融资余额5.31亿元

Group 1 - The core viewpoint of the news is that Chuangye Huikang's stock experienced a decline of 4.04% on November 20, with a trading volume of 350 million yuan, indicating a significant market reaction [1] - On November 20, Chuangye Huikang had a financing buy-in amount of 37.60 million yuan and a net financing buy of 8.33 million yuan, with a total financing and margin balance of 532 million yuan [1] - The financing balance of Chuangye Huikang is 531 million yuan, accounting for 6.56% of its circulating market value, which is above the 60th percentile level over the past year, indicating a high level of financing activity [1] Group 2 - Chuangye Huikang, established on December 10, 1997, and listed on May 14, 2015, operates in the healthcare information technology sector, with main business activities including software sales and system integration [2] - For the period from January to September 2025, Chuangye Huikang reported a revenue of 862 million yuan, a year-on-year decrease of 26.26%, and a net profit attributable to shareholders of -122 million yuan, a significant decline of 331.69% [2] - As of September 30, 2025, the number of shareholders of Chuangye Huikang was 64,400, a decrease of 0.69% from the previous period, while the average circulating shares per person increased by 0.70% to 23,711 shares [2] Group 3 - Chuangye Huikang has distributed a total of 230 million yuan in dividends since its A-share listing, with cumulative distributions of 30.94 million yuan over the past three years [3] - As of September 30, 2025, among the top ten circulating shareholders, Noan Active Return Mixed A held 16.10 million shares, a decrease of 8.03 million shares from the previous period [3] - Hong Kong Central Clearing Limited and Guorong Rongsheng Longtou Selected Mixed A have exited the list of the top ten circulating shareholders, indicating changes in institutional holdings [3]